1620 INVESTMENT ADVISORS, INC. - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,127 filers reported holding NOVARTIS A G in Q2 2022. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.

Quarter-by-quarter ownership
1620 INVESTMENT ADVISORS, INC. ownership history of NOVARTIS A G
ValueSharesWeighting
Q2 2023$891,641
+11.1%
8,836
+1.3%
0.97%
-0.1%
Q1 2023$802,700
+2.8%
8,725
+1.4%
0.97%
+2.4%
Q4 2022$780,555
+22.5%
8,604
+2.7%
0.94%
+0.5%
Q3 2022$637,000
-8.1%
8,381
+2.3%
0.94%
-1.7%
Q2 2022$693,000
-0.1%
8,196
+3.3%
0.96%
+26.6%
Q1 2022$694,0000.0%7,9320.0%0.76%
-2.8%
Q4 2021$694,0007,9320.78%
Other shareholders
NOVARTIS A G shareholders Q2 2022
NameSharesValueWeighting ↓
GODSEY & GIBB, INC 184,900$15,121,0006.74%
Martin Investment Management, LLC 289,924$23,710,0005.98%
Camber Capital Management LP 2,000,000$163,560,0005.04%
MANAGED ASSET PORTFOLIOS, LLC 381,778$31,222,0004.76%
PROFESSIONAL ADVISORY SERVICES INC 267,779$21,899,0003.22%
SCHARF INVESTMENTS, LLC 1,244,711$101,794,0003.21%
GARLAND CAPITAL MANAGEMENT INC 50,755$4,151,0002.97%
First Fiduciary Investment Counsel, Inc. 167,378$13,688,0002.67%
WILKINS INVESTMENT COUNSEL INC 130,590$10,680,0002.61%
Lowell Blake & Associates Inc. 66,309$5,423,0002.52%
View complete list of NOVARTIS A G shareholders